Vesper Healthcare Acquisition Corp. (NASDAQ: VSPR)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
Vesper Healthcare Acquisition Corp. (NASDAQ: VSPR) in connection with the company s proposed merger with privately-held The HydraFacial Company ( HydraFacial ). Under the terms of the agreement, VSPR will acquire HydraFacial through a reverse merger that will result in HydraFacial becoming a publicly traded company. If you own VSPR shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/vspr/
/PRNewswire/ If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this.
WeissLaw LLP Reminds BFT, RESI, CIT, and ALSK Shareholders About Its Ongoing Investigations
News provided by
Share this article
NEW YORK, Dec. 23, 2020 /PRNewswire/
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
Foley Trasimene Acquisition Corp. II (NYSE: BFT)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
Foley Trasimene Acquisition Corp. II (NYSE: BFT) in connection with the company s proposed merger with privately-held Paysafe Group Holdings Limited ( Paysafe ). Under the terms of the agreement, BFT will combine with Paysafe via a reverse merger that will result in Paysafe becoming a publicly traded company. If you own BFT shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above
Is FCNCA A Good Stock To Buy Now According To Hedge Funds? yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
American Renal Associates Holdings, Inc. (NYSE: ARA)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of ARA to affiliates of Nautic Partners for $11.50 per share.
If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
BridgeBio Pharma, Inc. (NASDAQ: BBIO) - Eidos Therapeutics, Inc. (EIDX)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of EIDX to BBIO for approximately $73.26 per share.